Literature DB >> 9443041

Barrett's oesophagus: microsatellite analysis provides evidence to support the proposed metaplasia-dysplasia-carcinoma sequence.

C M Gleeson1, J M Sloan, J A McGuigan, A J Ritchie, J L Weber, S E Russell.   

Abstract

The development of adenocarcinoma in Barrett's oesophagus is proposed to occur via a stepwise progression recognised histologically as a metaplasia-dysplasia-carcinoma sequence. In order to identify chromosomal loci involved in the malignant transformation of Barrett's epithelium and the development of oesophageal adenocarcinoma, microsatellite analysis was carried out on 17 cases of Barrett's-associated oesophageal adenocarcinoma. Samples of premalignant Barrett's epithelium adjacent to adenocarcinoma were obtained from seven of these cases. Allelic imbalance was detected in > 45% of informative cases of oesophageal adenocarcinoma on chromosome arms 3q (65%), 4q (71%), 5q (59%), 6q (59%), 9p (50%), 9q (47%), 12p (47%), 12q (65%), 17p (76%), and 18q (75%). Allelic imbalance at 4q, 17p, and 18q was significantly higher than the upper 95% confidence interval for background allelic imbalance. Allelic imbalance was detected at several loci in the premalignant epithelium from five of the seven cases studied. These loci included several chromosomal arms that had demonstrated high levels of allelic imbalance in oesophageal adenocarcinoma, namely, 4q (one case), 5q (two cases), 9 (three cases), 12q (five cases), 17p (four cases), and 18q (two cases). Novel microsatellite alleles were detected in both premalignant and malignant Barrett's epithelium. In three cases, dysplastic Barrett's epithelium and adjacent adenocarcinoma demonstrated the same pattern of novel microsatellite alleles at a number of loci. In conclusion, these data indicate chromosomal loci which may be specifically involved in the histological progression of Barrett's epithelium. The detection of shared novel microsatellite alleles in premalignant and malignant Barrett's epithelium is consistent with a process of clonal expansion underlying this progression.

Entities:  

Mesh:

Year:  1998        PMID: 9443041

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  12 in total

Review 1.  The clonal origin and clonal evolution of epithelial tumours.

Authors:  S B Garcia; M Novelli; N A Wright
Journal:  Int J Exp Pathol       Date:  2000-04       Impact factor: 1.925

Review 2.  Molecular biology of Barrett's adenocarcinoma.

Authors:  B P Wijnhoven; H W Tilanus; W N Dinjens
Journal:  Ann Surg       Date:  2001-03       Impact factor: 12.969

Review 3.  Clinical implications of molecular changes in pediatric Barrett's esophagus.

Authors:  Licia Pensabene; Marta C Cohen; Michael Thomson
Journal:  Curr Gastroenterol Rep       Date:  2012-06

4.  Chromosomal imbalances in Barrett's adenocarcinoma and the metaplasia-dysplasia-carcinoma sequence.

Authors:  A K Walch; H F Zitzelsberger; J Bruch; G Keller; D Angermeier; M M Aubele; J Mueller; H Stein; H Braselmann; J R Siewert; H Höfler; M Werner
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

5.  Microsatellite alterations in phenotypically normal esophageal squamous epithelium and metaplasia-dysplasia-adenocarcinoma sequence.

Authors:  Jian-Chun Cai; Di Liu; Kai-Hua Liu; Hai-Ping Zhang; Shan Zhong; Ning-Sao Xia
Journal:  World J Gastroenterol       Date:  2008-07-07       Impact factor: 5.742

6.  Differential effects of PPARgamma activation by the oral antidiabetic agent pioglitazone in Barrett's carcinoma in vitro and in vivo.

Authors:  Oliver H Al-Taie; Tilmann Graf; Bertram Illert; Tiemo Katzenberger; Hubert Mörk; Michael R Kraus; Hans U Barthelmes; Michael Scheurlen; Jochen Seufert
Journal:  J Gastroenterol       Date:  2009-06-09       Impact factor: 7.527

7.  Genetic alterations in Barrett esophagus and adenocarcinomas of the esophagus and esophagogastric junction region.

Authors:  T T Wu; T Watanabe; R Heitmiller; M Zahurak; A A Forastiere; S R Hamilton
Journal:  Am J Pathol       Date:  1998-07       Impact factor: 4.307

8.  Changing times. Annual oration: Royal Victoria Hospital, Belfast, October 2001.

Authors:  James M Sloan
Journal:  Ulster Med J       Date:  2002-05

9.  Frequent loss of the AXIN1 locus but absence of AXIN1 gene mutations in adenocarcinomas of the gastro-oesophageal junction with nuclear beta-catenin expression.

Authors:  L B Koppert; A W van der Velden; M van de Wetering; M Abbou; A M W van den Ouweland; H W Tilanus; B P L Wijnhoven; W N M Dinjens
Journal:  Br J Cancer       Date:  2004-02-23       Impact factor: 7.640

10.  Loss of heterozygosity at thymidylate synthase locus in Barrett's metaplasia, dysplasia, and carcinoma sequences.

Authors:  Hidekazu Kuramochi; Kazumi Uchida; Jeffery H Peters; Daisuke Shimizu; Daniel Vallbohmer; Sylke Schneider; Kathleen D Danenberg; Peter V Danenberg
Journal:  BMC Cancer       Date:  2009-05-21       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.